Overview

Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery

Status:
Completed
Trial end date:
2020-04-15
Target enrollment:
Participant gender:
Summary
We would like to evaluate and optimize opioid prescribing after minimally invasive hysterectomy. Currently, our standard prescribing is 150 oral morphine equivalents. However, recent studies show that half of the opioids prescribed are not used. We would like to include the patient in the decision making of the opioid prescribing. We have designed a randomized controlled trial to prescribe standard (150 oral morphine equivalents) or patient directed (less than or equal to 150 oral morphine equivalents) for pain control. We hypothesize that with patient input, there will be a higher utilization of the opioids prescribed. Also, we anticipate a lower number of opioids used overall. This study will help us optimize opioid prescribe and evaluate whether patient input can help in this important measure.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Analgesics, Opioid
Oxycodone